WHO Prequalifies its First Biosimilar

The World Health Organization (WHO) on Wednesday announced it has prequalified its first biosimilar, a year and a half after it invited manufacturers to submit applications for prequalifying biosimilars to two biologics on its Essential Medicines List, Roche’s Rituxan (rituximab) and Herceptin (trastuzumab).